Exploring The Neurobiological Foundations Of Anxiety Disorders: Advances And Challenges

Abstract

Anxiety disorders are among the most prevalent mental health conditions worldwide, with significant implications for the individual’s well-being and functionality. The neurobiological foundations of anxiety have been the subject of increasing research, leading to new insights into the brain regions and neurotransmitter systems involved in anxiety. This article reviews recent advances in our understanding of the neurobiology of anxiety disorders, focusing on the role of key brain structures such as the amygdala, prefrontal cortex, and hippocampus, as well as the involvement of neurotransmitters like serotonin, gamma-aminobutyric acid (GABA), and norepinephrine. Despite significant progress, several challenges remain in fully elucidating the complex neurobiological mechanisms underlying anxiety, especially in terms of developing effective, individualized treatments. This review also examines how genetic, environmental, and developmental factors interact in the pathophysiology of anxiety disorders, highlighting the need for a more integrated approach to treatment and research.